Related Experiment Video
Updated: Feb 14, 2026

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
Published on: September 16, 2020
Aflibercept Action in a Rabbit Model of Chronic Retinal Neovascularization: Reversible Inhibition of Pathologic
Jingtai Cao1, Thomas C MacPherson1, Bibiana V Iglesias1
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York, United States.
Purpose:
We establish and characterize the chronic retinal neovascularization (RNV) induced by intravitreal (IVT) injection of DL-α-aminoadipic acid (AAA) in a rabbit model and investigate the extent and duration of inhibitory actions induced by IVT aflibercept on the RNV.
Methods:
Rabbits received a single IVT injection of AAA, with weekly follow-up fundus photography, fluorescein angiography (FA), and optical coherence tomography (OCT). After 10 weeks, they received a single IVT aflibercept or control injection. RNV leakage was quantified from FA by image analysis with Photoshop. Some eyes were collected for histologic analysis.
Results:
IVT AAA produced neuronal degeneration over a large fraction of the retina. RNV formed in the damaged area and by 10 weeks exhibited stable morphology and leakage, which persisted for at least 65 weeks. Control IVT injections did not affect RNV leakage, but IVT aflibercept completely blocked RNV leakage. The inhibition was reversible (i.e., the leakage returned as the drug cleared), and the duration of antileak effects with 500 μg aflibercept was approximately 8 weeks. Partial regression of the pathologic vasculature also occurred with aflibercept, with reestablishment as the drug cleared.
Conclusions:
This model mimics a chronic human disease in its stability and persistence, and the antileak action of aflibercept is fully reversible with a dose-dependent duration. Therefore, this large eye model is uniquely suitable for investigations into the efficacy and duration of action of novel formulations and pharmacotherapies for retinal vascular diseases, and for studying the underlying pathobiology of retinal angiogenesis.
Insights
Intravitreal aflibercept effectively blocked leakage in a chronic retinal neovascularization rabbit model. The anti-leak effect was reversible, lasting about 8 weeks, and partially regressed abnormal vasculature.
Area of Science:
- Ophthalmology
- Retinal Vascular Diseases
- Pharmacology
Background:
- Chronic retinal neovascularization (RNV) is a significant cause of vision loss.
- Existing models may not fully replicate the stability and persistence of human RNV.
- Understanding the long-term effects of anti-angiogenic therapies is crucial.
Purpose of the Study:
- To establish and characterize a chronic RNV rabbit model using intravitreal (IVT) DL-α-aminoadipic acid (AAA).
- To investigate the inhibitory effects and duration of IVT aflibercept on established RNV in this model.
- To assess the reversibility and dose-dependency of aflibercept's anti-leak action.
Main Methods:
- Induction of chronic RNV in rabbits via single IVT AAA injection.
- Weekly monitoring using fundus photography, fluorescein angiography (FA), and optical coherence tomography (OCT).
- Administration of IVT aflibercept or control injection at 10 weeks, followed by leakage quantification and histological analysis.
Main Results:
- IVT AAA successfully induced stable RNV with persistent leakage for over 65 weeks.
- IVT aflibercept completely blocked RNV leakage, with effects lasting approximately 8 weeks for 500 μg.
- Aflibercept demonstrated reversible anti-leak effects and induced partial regression of pathologic vasculature.
Conclusions:
- The AAA-induced RNV rabbit model accurately mimics chronic human retinal vascular diseases.
- Aflibercept's anti-leak action is fully reversible and exhibits dose-dependent duration.
- This model is valuable for studying novel pharmacotherapies and the pathobiology of retinal angiogenesis.
More Related Videos
09:56In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model
Published on: January 21, 2018
08:41Calvarial Model of Bone Augmentation in Rabbit for Assessment of Bone Growth and Neovascularization in Bone Substitution Materials
Published on: August 13, 2019
Related Concept Videos
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
Drug Toxicity: Dose-Dependent Reactions
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Feedback Inhibition
Fixed Action Patterns
Modeling of Diode Reverse Characteristics
When a reverse voltage applied to a Zener diode exceeds its breakdown voltage, the diode enters the breakdown region. At this point, the...